Dopamine D2 receptor imaging inGilles de la Tourette syndrome
暂无分享,去创建一个
H Hundeshagen | G J Meyer | H. Emrich | G. Meyer | H. Hundeshagen | K. Müller-Vahl | G. Berding | R. Dengler | G Berding | H Kolbe | R Dengler | W H Knapp | H M Emrich | K R Müller-Vahl | H. Kolbe | W. Knapp | Geerd J. Meyer | Heinz Hundeshagen | Hinderk M. Emrich | Georg Berding | Wolfram H. Knapp | Reinhard Dengler | Kirsten Müller-Vahl
[1] G. S. Golden,et al. The relationship between stimulant medication and tics. , 1988, Pediatric annals.
[2] C. Kirsch,et al. SPECT imaging of dopamine D2 receptors with 123I‐IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease , 1991, Nuclear medicine communications.
[3] Mary M. Robertson,et al. Annotation: Gilles de la Tourette syndrome--an update. , 1994, Journal of child psychology and psychiatry, and allied disciplines.
[4] H. Singer,et al. Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome , 1991, Annals of neurology.
[5] A. Alavi,et al. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] C. Halldin,et al. Comparison of the In Vitro Receptor Binding Properties of N‐[3H]Methylspiperone and [3H]Raclopride to Rat and Human Brain Membranes , 1990, Journal of neurochemistry.
[7] R. Coppola,et al. Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding , 1996, Science.
[8] M. Ichise,et al. Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans. , 1993, Annals of Nuclear Medicine.
[9] K. Leenders,et al. Comparison of 123I‐IBZM SPECT and 11C‐raclopride PET findings in patients with parkinsonism , 1994, Nuclear medicine communications.
[10] M. Trimble,et al. Dopamine receptor availability in Tourette's syndrome , 1994, Psychiatry Research: Neuroimaging.
[11] G. Sawle,et al. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[12] L. Deecke,et al. D2 Receptor Blockade by Flunarizine and Cinnarizine Explains Extrapyramidal Side Effects. A SPECT Study , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] A. Shapiro,et al. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. , 1989, Archives of general psychiatry.
[14] A. Gjedde,et al. D2-like dopamine receptor density in Tourette syndrome measured by PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] J. Coyle,et al. Dopaminergic dysfunction in tourette syndrome , 1982 .
[16] G. Erenberg,et al. The natural history of Tourette syndrome: A follow‐up study , 1987, Annals of neurology.
[17] R. Caprioli,et al. Biogenic amine metabolism in tourette syndrome , 1979, Annals of neurology.
[18] G. Stebbins,et al. Adult tics in Gilles de la Tourette's syndrome , 1992, Neurology.
[19] A. Alavi,et al. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] L. Nee,et al. Tourette syndrome: clinical and family studies. , 1982, Advances in neurology.
[21] R. G. Manning,et al. High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] B. Shaywitz,et al. Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration. , 1978, Archives of general psychiatry.
[23] R. Bruun,et al. The natural history of Tourette syndrome. , 1992, Advances in neurology.
[24] L. Deecke,et al. Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] J. Palacios,et al. Dopamine receptors in human brain: Autoradiographic distribution of D2 sites , 1989, Neuroscience.
[26] N. P. L. G. VERHOEFF,et al. Dynamic SPECT in two healthy volunteers to determine the optimal time for in vivo D2 dopamine receptor imaging with123I‐IBZM using the rotating gamma camera , 1991, Nuclear medicine communications.